Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: DCR
Name: Down syndrome chromosome region
Location: 21q22.3
Locus Group: other
Gene Type: Protein Coding
Locus Type: region
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT04191889 A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification View
NCT01010659 The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora View
NCT04211896 Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer View
NCT04507906 Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC View
NCT01295827 Study of Pembrolizumab MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma Melanoma or Non-small Cell Lung Carcinoma P07990MK-3475-001KEYNOTE-001 View
NCT01772277 Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy A Systematic Review and Meta-Analysis View
NCT05812534 Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases View
NCT06461910 Efficacy and Safety of Anti-PD-1 Thymosin and SOX in Neoadjuvant Treatment of cStage III GastricGEJ Adenocarcinoma View
NCT04061512 Rituximab and Ibrutinib RI Versus Dexamethasone Rituximab and Cyclophosphamide DRC as Initial Therapy for Waldenströms Macroglobulinaemia View
NCT02718066 Study of HBI-8000 With Nivolumab in Melanoma Renal Cell Carcinoma and Non-Small Cell Lung Cancer View
NCT02738697 Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection View
NCT02795325 A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 PH1 View
NCT04060472 Paclitaxel Albumin-bound and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors View
NCT02821091 Biomechanics Research in the Effects of Interactive Dynamic Balance Training on Postural and Gait Control in Older Adults View
NCT02993770 Endo-nasal Endoscopic DCR and External-DCR in Primary Nasolacrimal Duct Obstruction View
NCT04230187 Bevacizumab Plus MFOLFOXIRI As First-line Treatment for Patients with Unresectable Metastatic Colorectal Cancer View
NCT04967079 Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients View
NCT03694977 Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancer View
NCT06643533 Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC TALENP004 View
NCT06538012 TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer View
NCT04218136 Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study View
NCT04331626 Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC View
NCT04489706 Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation View
NCT04547725 Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis View
NCT06043973 Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance View
NCT05563844 Study of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma DLBCL View
NCT05574998 First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene a Multicenter Single-Arm Trial View
NCT04825990 Pembrolizumab and Olaparib in RecurrentMetastatic Platinum Resistant Nasopharyngeal Cancer View
NCT06406673 A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer View
NCT06175676 Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis View
NCT05241054 Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation View
NCT05267327 A Prospective Post-Marketing Observational Safety Study of Verzenios Abemaciclib Among Breast Cancer Patients in China Verzenios Abemaciclib Among Breast View
NCT06250777 Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases View
NCT01949194 Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers View
NCT05494866 A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma View
NCT02425137 A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer View
NCT05608785 Single-center Multi-cohort Exploratory Phase IbII Clinical Study of First-line Treatment of Unresectable Locally AdvancedAdvanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes View
NCT05735093 Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury View
NCT05201612 Pembrolizumab and Olaparib in Homologous-recombination Deficient HRD Advanced Colorectal Cancer CRC View
NCT05997459 A Single Arm Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant View
NCT06076135 Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors View
NCT06122051 Dynamic Chest X-ray With Simultaneous Spirometry View
NCT06454448 Phase IbII Clinical Study of Adebrelimab in Combination With Decitabine Albumin-bound Paclitaxel and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer View
NCT04394624 Tusamitamab Ravtansine SAR408701 in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC CARMEN-LC04 View
NCT01459614 GemcitabineTaxotereXeloda GTX With Cisplatin in Subjects With Metastatic Pancreatic Cancer View
NCT04475900 Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics View
NCT03392896 Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria View
NCT01530334 Iressa Re-Challenge in Advanced NSCLC EGFR M Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment View
NCT01951469 Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer View
NCT01951482 PemetrexedCisplatin With or Without Bevacizumab in Brain Metastases From Non Squamous Non-small Cell Lung Cancer View
NCT04555486 Study to Evaluate Safety Tolerability PK and PD of DCR-PHXC in PH Type 3 Patients View
NCT00784992 A Comparison of Endonasal Dacryocystorhinostomy With and Without Silicone Tubes View
NCT02314052 Phase Ib2 Multicenter Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma View
NCT00988897 Colorectal Cancer RECHALLENGE View
NCT01722890 CharactHer ICORG 12-09 V3 View
NCT01204177 Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer View
NCT03411356 Intermittent Fasting Versus Daily Caloric Restriction for Weight Loss View
NCT01221909 Tranexamic Acid in Dacryocystorhinostomy View
NCT04790409 Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations View
NCT04831658 A Prospective Clinical Study of BTK Inhibitor PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma View
NCT04882462 Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of RM HNSCC View
NCT01524848 Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib View
NCT04901741 Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or GemcitabineNab-Paclitaxel in MSS Pancreatic Cancer View
NCT04182698 Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC View
NCT01616199 Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma View
NCT03103724 A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer mCRPC Patients With Visceral Disease View
NCT04995419 A Study to Evaluate Enfortumab Vedotin ASG-22CE in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 PD 1 Programmed Death Ligand-1 PD-L1 Inhibitor Therapy View
NCT05005442 A Study of PembrolizumabVibostolimab MK-7684A in RelapsedRefractory Hematological Malignancies MK-7684A-004 KEYVIBE-004 View
NCT01703455 Activity of Sorafenib in Salivary Gland Cancer View
NCT05128734 Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer TNBC View
NCT05214339 A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification D-TRIPLET View
NCT01933347 Third-line Treatment of Gefitinib in NSCLC Patients View
NCT02664103 Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer View
NCT03350126 iRECIST Evaluations Relevance for DCR in MMRMSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab View
NCT05313282 A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification View
NCT05322720 HR Positive HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy View
NCT05338892 Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for RelapsedRefractory Diffuse Large B-Cell Lymphoma View
NCT05338879 Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma View
NCT03250676 Trial of H3B-6545 in Women With Locally Advanced or Metastatic Estrogen Receptor-positive HER2 Negative Breast Cancer View
NCT04021407 Laryngeal Mask Airway Versus Air Q Laryngeal Airway View
NCT05466149 Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion View
NCT03304093 Immunotherapy by Nivolumab for HIV Patients View
NCT05500950 Color Doppler Ultrasound in Lacrimal Sac Space-occupying Lesions View
NCT03499626 Phase 1b of ASLAN001 Varlitinib in Patients With Advanced Metastatic Hepatocellular Carcinoma HCC View
NCT03517618 TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC View
NCT05591560 Itraconazole in Advanced Ovarian Cancer View
NCT02497508 Nivolumab in Patients With Recurrent Malignant Mesothelioma View
NCT03579784 Biomarker-oriented Study of Durvalumab MEDI4736 in Combination With Olaparib and Paclitaxel in Gastric Cancer View
NCT05673447 The Study of Anti-CD19 CAR NK Cells in the Treatment of RelapsedRefractory Diffuse Large B Cell Lymphoma View
NCT01826734 Analysis of 86 Dacryoliths at the University Hospital Ostrava View
NCT02659540 Pilot Study of the SafetyEfficacy of Combination Checkpoint Blockade External Beam Radiotherapy in Stage IV Melanoma View
NCT05736952 Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer View
NCT03628521 First-line Combination Treatment Based on Anlotinib View
NCT02774200 A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients View
NCT05809336 Gut Microbial Metabolites Inosine Combined With PD-1PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors View
NCT05810350 Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles View
NCT05831969 Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC View
NCT04542590 Natural History of Patients With PH3 and a History of Stone Events View
NCT04300595 Anesthetic Approaches for Dacryocystorhinostomy Surgery The Effect of Adding Local Anesthesia to General Inhalational Anesthesia View
NCT05943795 A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma View
NCT05978050 Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma View
NCT03114683 Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With RelapsedRefractory Classical Hodgkins Lymphoma View
NCT06022692 Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours View
NCT00571129 Endoscopic Dacryocystorhinostomy Prospective Research View
NCT06098651 A Study of DCR-STAT3 in Adults With Solid Tumors View
NCT06102928 A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation View
NCT04580420 Safety Efficacy of DCR-PHXC in Patients With PH12 and ESRD View
NCT03299452 Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor View
NCT05472896 TACE With DicycloplatinTP21 in Unresectable HCC View
NCT06141369 Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine mRNA-0523-L001 View
NCT06157996 Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GCGEJC With Positive PD-L1 and Low TMEscore View
NCT06169410 Ramucirumab Combined With Nab-paclitaxel Lobaplatin and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer View
NCT03407300 A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer NSCLC Patients View
NCT04793230 Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy View
NCT03444077 Impact of a Prehospital Identification of Trauma Patients in Need for Damage Control Resuscitation View
NCT03487380 Taxonomic and Functional Composition of the Intestinal Microbiome a Predictor of Rapid Cognitive Decline in Patients With Alzheimers Disease View
NCT06224049 Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T View
NCT04820179 Atezolizumab Cabozantinib in Patients W Metastatic Refractory Pancreatic Cancer View
NCT04858958 Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation View
NCT06341400 RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients View
NCT03772249 Study of Safety and Tolerability of DCR HBVS View
NCT04764448 A Study of Belcesiran in Patients With AATLD View
NCT03780868 External DCR Versus Canalicular SI With MMC in NLDO View
NCT03847909 A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 View
NCT04952454 Functional Epiphora Management Via Different Dacryocystorhinostomy DCR Techniques View
NCT03869294 GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients View
NCT06441344 Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell View
NCT06494579 Lamivudine for Solid Tumors View
NCT06469190 An Exploratory Clinical Study of Anti-CD19 CAR NK Cell KN5501 in the Treatment of RelapsedRefractory Immune Nephropathy View
NCT04174118 Study of DCR-A1AT in Healthy Adult Volunteers View
NCT05001269 Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function View
NCT04042402 Long Term Extension Study in Patients With Primary Hyperoxaluria View
NCT06518018 Efficacy and Safety of High-Dose Rate Brachytherapy with Immunotherapy and Chemotherapy As Second-Line Treatment for Advanced Non-Small Cell Lung Cancer View
NCT06530303 Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer View
NCT06530823 Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma View
NCT06532799 TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer View
NCT04126993 Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma View
NCT04126811 Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma View
NCT05071053 Tusamitamab Ravtansine SAR408701 in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer View
NCT05906329 Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance View
NCT04409028 The Effect of Coronal Restoration Type on Satisfaction Patients View
NCT05920863 Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors View
NCT04632459 Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer View
NCT04668508 Anlotinib to Malignant Brainstem Glioma View
NCT05845398 Phase 1b Study of DCR-AUD in Healthy Volunteers View
NCT02726854 Apatinib as Second-line Treatment of Advanced Pancreatic Cancer View
NCT01527877 Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck View
NCT04833452 Comparative Study Between Wide and Narrow Fenstrum Endoscopic DCR View
NCT06232265 An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore View
NCT06341309 Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer View
NCT05021640 Study of DCR-AUD in Healthy Volunteers View
NCT05031572 Energy -Sensing Metabolites in Caloric Restriction View
NCT06136910 Oncorine H101 Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer View
NCT05062837 Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC View
NCT05065957 Study of Combination Therapy of D07001-Softgel Capsules and XelodaTS-1 in Subjects With Advanced Biliary Tract Cancer View
NCT05138302 A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients View
NCT05146882 An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease AATLD View
NCT06607809 Inflammatory Markers ICC MCVL and Nivolumab Response Predicting Immunotherapy Success in Metastatic RCC View
NCT05244993 AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer View
NCT06400160 Clinical Trial of TB511 in Advanced Solid Tumors View
NCT05346328 HER2-positive Breast Cancer Project Initiated by Investigators View
NCT05397301 Controlled Sedoanalgesia in External DCR Surgery View
NCT06607107 mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage AB Hepatocellular Carcinoma Patients Beyond Milan Criteria View
NCT06504368 Safety Tolerability and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors View
NCT05455944 Analgesic Efficacy of Pre-operative Oral Pregabalin in Dacryocystorhinostomy Surgery View
NCT06511726 Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer View
NCT05507476 Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy View
NCT05551208 Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi View
NCT01955421 Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc View
NCT05625893 Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion View
NCT05648071 First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene a Single-center Single-Arm Trial View
NCT02588261 A Study of ASP8273 vs Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIBIV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations View
NCT05659290 Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer View
NCT06464965 Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer View
NCT06530264 Evaluation of Different Methods of Posterior Flap Management in External Dacryocystorhinostomy View
NCT06532539 Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma View
NCT06532812 TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer View
NCT05916261 Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer View
NCT05916248 Personalized Tumor Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors View
NCT05927857 Ramucirumab Cyramza Nal-IRI ONIVYDE and TrifluridineTipiracil Lonsurf in Second Line Metastatic Gastric Cancer View
NCT02044614 Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis View
NCT05933980 ToripalimabCelecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer View
NCT02042144 Safety and Effectiveness of Regorafenib View
NCT06640582 TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas View
NCT05964699 The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain MI Compared to Traditional SRCP View
NCT05969899 Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer View
NCT05993416 Treatment of Primary Hyperoxaluria Type 1 With Nedosiran View
NCT06010888 Fruquintinib With mFOLFOX6FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC View
NCT06175455 Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography View
NCT06195085 CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors View
NCT06305702 Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer View
NCT06346561 The Efficacy of Dexmedetomidine Versus Labetalol In Providing Controlled Hypotension In Dacryocystorhinostomy SurgeryA Comparative Randomized Prospective Study View
NCT06363006 Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer View
NCT06395246 Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs View
NCT06437678 Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer View
NCT06495463 Lonsurf TrifluridineTipiracil Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan View
NCT02110563 Phase I Multicenter Dose Escalation Study of DCR-MYC in Patients With Solid Tumors Multiple Myeloma or Lymphoma View
NCT04453423 Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer View
NCT05280457 HPV 16-positive andor HPV 18-positive Recurrent andor For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination GX-I7 and Nivolumab Combination Therapy View
NCT02145312 An Open Label Single Arm Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy View
NCT05241132 Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary View
NCT02501551 Regorafenib C-kit Mutated Malignant Melanoma 2nd Line Therapy View
NCT04958473 A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer View
NCT01500824 A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase ALK Positive Advanced Non-Small Cell Lung Cancer View
NCT04182789 KN035 in Patients With Advanced Multiple Primary Tumors View
NCT05402865 A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone View
NCT05427305 TAB008 Compared to Avastin in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer View
NCT05436990 Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor View
NCT05477615 LazertinibPemetrexedCarboplatin After Osimertinib Failure in NSCLC With Brain Metastases View
NCT05550025 TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer View
NCT02299765 Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC View
NCT02293005 Phase II Trial of Alisertib MLN8237 in Salvage Malignant Mesothelioma View
NCT00732914 Sequential Study to Treat Renal Cell Carcinoma View
NCT02609958 ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy View
NCT02984683 Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer View
NCT03192345 A First-in-human Study of the Safety Pharmacokinetics Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors View
NCT03251443 A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma View
NCT03260322 A Multiple-dose Study of ASP8374 an Immune Checkpoint Inhibitor as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors View
NCT03387592 CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas View
NCT03474107 A Study to Evaluate Enfortumab Vedotin Versus vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer EV-301 View
NCT03705000 SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction View
NCT03869034 HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC View
NCT03871348 A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors View
NCT03940404 Anlotinib Therapy in Patients With Advanced Lung Cancer View
NCT03960996 Long Term Effectiveness of Dacryocystorinostomy With and Without Bicanalicular Intubation View
NCT04009681 A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors THOR-707-101 View
NCT04054791 Endonasal Dacryocystorhinostomy and Evolution of the Stoma Size View